Z67.A2
Duffy a positive
Clinical Classification Guidelines
Inclusion Terms
- Duffy phenotype Fy(a+b-)
Medical Intelligence & Overview
The Duffy blood group system is an important aspect of human blood typing that has implications for blood transfusions and susceptibility to certain diseases. The Duffy a positive (Z67.A2) phenotype refers to a specific variation in the Duffy blood group, characterized by the presence of the Duffy antigen Fy(a+b-). This condition can influence how the immune system interacts with foreign cells and pathogens.
Causes & Symptoms
Clinical Causes: Genetic inheritance of the Duffy blood group alleles, specifically the presence of the Fy(a) antigen and the absence of Fy(b). Inherited genetic variation that results in the expression of the Fy(a+b-) phenotype. Certain populations, particularly those of African descent, more commonly carry the Fy(a+b-) phenotype.
Key Symptoms: Typically, there are no physical symptoms associated with being Duffy a positive. Some individuals may experience implications related to blood transfusions if compatibility is not properly determined.
Diagnostic & Treatment
Diagnosis Path: The Duffy a positive phenotype is identified through blood testing that determines the presence of specific antigens on the surface of red blood cells. Type-specific antibody testing and blood grouping assays are utilized in laboratories to establish the Duffy blood group status.
Treatment Protocols: There is no treatment required specifically for the Duffy a positive status. However, awareness of this phenotype is important for blood transfusion compatibility. Individuals may need blood matching for transfusions to prevent incompatibility reactions. Additional management may be involved if the phenotype is linked to susceptibility to certain infections, but this is determined on a case-by-case basis by healthcare professionals.
Clinical Advice & FAQs
Billing Guidance
Is Z67.A2 a billable ICD-10 code?
Yes, Z67.A2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z67.A2?
Clinical documentation must specify the nature of Duffy a positive and any associated comorbidities for accurate reporting.
Cite this Clinical Reference